use vaccine influenza virus remain effect method mining signifies morbid mortal caps antibody elicit current license vaccine predominantly hemagglutinationinhibit hicompet target globular head hemagglutinin ha thu inhibit entry cell confer homosubtypicstrain specify protect rare heterosubtyp howe recent academia pharma rd toward product universe vaccine center elicit direct stalk shown broad across rang differ subtype hh occur density measure antibody response nextgener hamper lack density trait secolo assay hi single radial hemolysi microneutr until pseudonym chime virus bear glycoprotein highly office homosubtyp broadly neutral make ideal tool studi crossprotect multiple tandem potent review analyze compare literature involve particular emphasis serum neutral enable unit state establish parapet require optic propos consensus protocol employ deploy immunogen studi 